Longevity.Technology (@LongevityTech)· LongevityTech·· 3 小时前评分8
Rona授予罗氏ALK7候选药全球权益
Rona Therapeutics grants Roche worldwide rights to an ALK7-silencing candidate, with up to $1.06b in further milestones on the table.
导读
Rona Therapeutics 将一款沉默 ALK7 的候选药物全球权益授予罗氏，另有最高 10.6 亿美元的里程碑款项。 https://vist.ly/5pg62 #longevity #RonaTherapeutics #Roche #ALK7 #biotech
来源：Longevity.Technology (@LongevityTech) · x.com